Concomitant Medication, Adverse Events Forms

Administrative data
Description

Administrative data

Subject Number
Description

Subject Number

Data type

integer

CONCOMITANT VACCINATION
Description

CONCOMITANT VACCINATION

Have any other than the study vaccine(s) been administered during the timeframe as specified in the Protocol?
Description

If Yes, please record concomitant vaccination with trade name and / or generic name, route and vaccine administration date.

Data type

boolean

Concomitant Vaccination Details
Description

Concomitant Vaccination Details

Trade/Generic Name
Description

Trade/Generic Name

Data type

text

Route
Description

Route

Data type

integer

Administration Date
Description

Administration Date

Data type

date

CONCOMITANT MEDICATION
Description

CONCOMITANT MEDICATION

Have any medications/treatments been administered during the time frame as specified in the Protocol?
Description

iF Yes, please complete the following information

Data type

boolean

Concomitant Medications Details
Description

Concomitant Medications Details

Trade/Genereic Name
Description

Trade/Genereic Name

Data type

text

Was the administration prophylactic?
Description

Prophylactic Administration

Data type

boolean

Medical Indication
Description

Medical Indication

Data type

text

Total daily dose
Description

Total daily dose

Data type

text

Route
Description

Route

Data type

integer

If Other, please specify
Description

Specify Other

Data type

text

Start Date
Description

Start Date

Data type

date

End Date
Description

End Date

Data type

date

Is the event continuing?
Description

Ongoing?

Data type

boolean

NON-SERIOUS ADVERSE EVENTS
Description

NON-SERIOUS ADVERSE EVENTS

Has any non-serious adverse events occurred within minimum 30 days post-vaccination, excluding those recorded on the Solicited Adverse Events forms?
Description

If Yes, please complete the following information.

Data type

boolean

Non-Serious Adverse Events Log
Description

Non-Serious Adverse Events Log

Episode Number
Description

Episode Number

Data type

integer

Description
Description

Description

Data type

text

Was the Adverse Event at the administration site?
Description

Administration Site

Data type

text

Please record the vaccine
Description

vaccine

Data type

text

Date started
Description

Date started

Data type

date

Date stopped
Description

Date stopped

Data type

date

Intensity
Description

Intensity

Data type

text

Is there a reasonable possibility that the AE may have been caused by the investigational product?
Description

Relationship To Investigational Products

Data type

boolean

Outcome
Description

Outcome

Data type

text

Medically attended visit
Description

Medically attended visit

Data type

boolean

If Yes, please specify type
Description

Medical Attendance Type

Data type

text

STUDY CONCLUSION
Description

STUDY CONCLUSION

If a booster study or a follow-up study is offered in the future, would the subject be willing to be contacted and learn more about it?
Description

please specify the most appropriate reason in the next part

Data type

boolean

Reason for Non-participation:
Description

Reason for Non-participation

Data type

text

Comment
Description

Comment

Data type

text

OCCURRENCE OF SERIOUS ADVERSE EVENT
Description

OCCURRENCE OF SERIOUS ADVERSE EVENT

Did the subject experience any Serious Adverse Event during the study?
Description

Occurrence of SAE

Data type

boolean

If Yes, Specify total number of SAE's:
Description

Specify Number of SAE

Data type

integer

STATUS OF TREATMENT BLIND
Description

STATUS OF TREATMENT BLIND

Was the treatment blind broken during the study?
Description

Status of the Treatment Blind

Data type

boolean

If Yes, complete date and tick one reason below.
Description

Treatment Blind Broken

Data type

date

Reason for the treatment line break
Description

Reason Treatment Blind Broken

Data type

text

if Other, please specify
Description

Specify Other

Data type

text

ELIMINATION CRITERIA
Description

ELIMINATION CRITERIA

Did any elimination criteria become applicable during the study?
Description

Elimination Criteria

Data type

boolean

If Yes, please specify
Description

Specify Elimination Criteria

Data type

text

Was the subject withdrawn from the study?
Description

Subject Withdrawn

Data type

boolean

Major reason for withdrawal
Description

Major Reason for Withdrawal

Data type

text

Specify Number of SAE
Description

Specify Number of SAE

Data type

integer

Specify Number of AE
Description

Specify Number of AE

Data type

integer

Please specify the typo of protocol violation
Description

Protocol Violation Specify

Data type

text

If Other, please specify below
Description

Specify Other

Data type

text

Who made the decision:
Description

Who made the decision

Data type

text

Date of last contact:
Description

Date of last contact

Data type

date

Was the subject in good condition at date of last contact?
Description

If No -> Please give details in Adverse Events section

Data type

boolean

INVESTIGATOR'S SIGNATURE
Description

INVESTIGATOR'S SIGNATURE

I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
Description

Investigator's Confirmation

Data type

date

Investigator's signature:
Description

Investigator's signature

Data type

text

Printed Investigator's name:
Description

Printed Investigator's name

Data type

text

Similar models

Concomitant Medication, Adverse Events Forms

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative data
Subject Number
Item
Subject Number
integer
Item Group
CONCOMITANT VACCINATION
Concomitant Vaccination Question
Item
Have any other than the study vaccine(s) been administered during the timeframe as specified in the Protocol?
boolean
Item Group
Concomitant Vaccination Details
Trade/Generic Name
Item
Trade/Generic Name
text
Item
Route
integer
Code List
Route
CL Item
Intradermal (1)
CL Item
Inhalation (2)
CL Item
Intramuscular (3)
CL Item
Intravenous (4)
CL Item
Intranasal (5)
CL Item
Parenteral (6)
CL Item
Oral (7)
CL Item
Subcutaneous (8)
CL Item
Sublingual (9)
CL Item
Transdermal (10)
CL Item
Unknown (11)
CL Item
Other (12)
Administration Date
Item
Administration Date
date
Item Group
CONCOMITANT MEDICATION
concomitant medications / treatments
Item
Have any medications/treatments been administered during the time frame as specified in the Protocol?
boolean
Item Group
Concomitant Medications Details
Trade/Genereic Name
Item
Trade/Genereic Name
text
Prophylactic Administration
Item
Was the administration prophylactic?
boolean
Medical Indication
Item
Medical Indication
text
Total daily dose
Item
Total daily dose
text
Item
Route
integer
Code List
Route
CL Item
Intradermal (1)
CL Item
Inhalation (2)
CL Item
Intramuscular (3)
CL Item
Intravenous (4)
CL Item
Intranasal (5)
CL Item
Parenteral (6)
CL Item
Oral (7)
CL Item
Subcutaneous (8)
CL Item
Sublingual (9)
CL Item
Transdermal (10)
CL Item
Vaginal (11)
CL Item
Unknown (12)
CL Item
Other (13)
Specify Other
Item
If Other, please specify
text
Start Date
Item
Start Date
date
End Date
Item
End Date
date
Ongoing?
Item
Is the event continuing?
boolean
Item Group
NON-SERIOUS ADVERSE EVENTS
Non-Serious AE
Item
Has any non-serious adverse events occurred within minimum 30 days post-vaccination, excluding those recorded on the Solicited Adverse Events forms?
boolean
Item Group
Non-Serious Adverse Events Log
Episode Number
Item
Episode Number
integer
Description
Item
Description
text
Item
Was the Adverse Event at the administration site?
text
Code List
Was the Adverse Event at the administration site?
CL Item
administrationsite (1)
CL Item
non-administration site (2)
Item
Please record the vaccine
text
Code List
Please record the vaccine
CL Item
Hib-MenC vaccine (1)
CL Item
Priorix vaccine (2)
Date started
Item
Date started
date
Date stopped
Item
Date stopped
date
Item
Intensity
text
Code List
Intensity
CL Item
mild (1)
CL Item
moderate (2)
CL Item
severe (3)
Relationship To Investigational Products
Item
Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
Item
Outcome
text
Code List
Outcome
CL Item
Recovered/Resolved (1)
CL Item
Recovering/Resolving (2)
CL Item
Not recovered/Not resolved (3)
CL Item
Recovered with sequelae/Resolved with sequelae (4)
Medically attended visit
Item
Medically attended visit
boolean
Item
If Yes, please specify type
text
Code List
If Yes, please specify type
CL Item
Hospitalization (1)
CL Item
Emergency Room (2)
CL Item
Medical Personnel (3)
Item Group
STUDY CONCLUSION
Potential Follow-up Study Participation
Item
If a booster study or a follow-up study is offered in the future, would the subject be willing to be contacted and learn more about it?
boolean
Item
Reason for Non-participation:
text
Code List
Reason for Non-participation:
CL Item
Adverse Events, or Serious Adverse Events (1)
CL Item
Other (2)
Comment
Item
Comment
text
Item Group
OCCURRENCE OF SERIOUS ADVERSE EVENT
Occurrence of SAE
Item
Did the subject experience any Serious Adverse Event during the study?
boolean
Specify Number of SAE
Item
If Yes, Specify total number of SAE's:
integer
Item Group
STATUS OF TREATMENT BLIND
Status of the Treatment Blind
Item
Was the treatment blind broken during the study?
boolean
Treatment Blind Broken
Item
If Yes, complete date and tick one reason below.
date
Item
Reason for the treatment line break
text
Code List
Reason for the treatment line break
CL Item
Medical emergency requiring identification of investigational product for further treatments. (1)
CL Item
Other (2)
Specify Other
Item
if Other, please specify
text
Item Group
ELIMINATION CRITERIA
Elimination Criteria
Item
Did any elimination criteria become applicable during the study?
boolean
Specify Elimination Criteria
Item
If Yes, please specify
text
Subject Withdrawn
Item
Was the subject withdrawn from the study?
boolean
Item
Major reason for withdrawal
text
Code List
Major reason for withdrawal
CL Item
Serious adverse event (1)
CL Item
Non-Serious adverse event (2)
CL Item
Protocol violation (3)
CL Item
Consent withdrawal, not due to an adverse event (4)
CL Item
Migrated / moved from the study area (5)
CL Item
Lost to follow-up (6)
CL Item
Other (7)
Specify Number of SAE
Item
Specify Number of SAE
integer
Specify Number of AE
Item
Specify Number of AE
integer
Protocol Violation Specify
Item
Please specify the typo of protocol violation
text
Specify Other
Item
If Other, please specify below
text
Item
Who made the decision:
text
Code List
Who made the decision:
CL Item
Investigator (1)
CL Item
Subject (2)
Date of last contact
Item
Date of last contact:
date
Subject Status
Item
Was the subject in good condition at date of last contact?
boolean
Item Group
INVESTIGATOR'S SIGNATURE
Investigator's Confirmation
Item
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
date
Investigator's signature
Item
Investigator's signature:
text
Printed Investigator's name
Item
Printed Investigator's name:
text